FlawCheck Citator
Check how courts have cited this case. Use our free citator for the most current treatment.
No. 9417045
United States Court of Appeals for the Ninth Circuit

Timothy Dunlap v. Imsi

No. 9417045 · Decided July 31, 2023
No. 9417045 · Ninth Circuit · 2023 · FlawFinder last updated this page Apr. 2, 2026
Case Details
Court
United States Court of Appeals for the Ninth Circuit
Decided
July 31, 2023
Citation
No. 9417045
Disposition
See opinion text.
Full Opinion
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS JUL 31 2023 MOLLY C. DWYER, CLERK U.S. COURT OF APPEALS FOR THE NINTH CIRCUIT TIMOTHY ALLAN DUNLAP, No. 22-35253 Plaintiff-Appellant, D.C. No. 1:20-cv-00555-CWD v. MEMORANDUM* IMSI; CAMPBELL, Dr., Defendants-Appellees. Appeal from the United States District Court for the District of Idaho Candy W. Dale, Magistrate Judge, Presiding Submitted July 31, 2023** San Francisco, California Before: WALLACE, O’SCANNLAIN, SILVERMAN, Circuit Judges. Prisoner Timothy A. Dunlap—a death-penalty inmate incarcerated at the Idaho Maximum Security Institution—asserts that he requested to be placed in the prison’s Acute Mental Health Unit based on his mental health condition, but that the prison and its officials unlawfully denied his request. He appeals pro se from the * This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3. ** The panel unanimously concludes this case is suitable for decision without oral argument. See Fed. R. App. P. 34(a)(2). district court’s decisions (1) granting summary judgment rejecting his claims, and (2) denying his motion for reconsideration. Because the facts are known to the parties, we repeat them only as necessary to explain our decision. I Dunlap’s first line of attack fails—the district court did not err in granting summary judgment rejecting Dunlap’s claims. Summary judgment is appropriate when “there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law,” Fed. R. Civ. P. 56(a)—and although pro se inmates are excused from “strict compliance with the summary judgment rules,” they are not excused “from all compliance.” Soto v. Sweetman, 882 F.3d 865, 872 (9th Cir. 2018); see Celotex Corp. v. Catrett, 477 U.S. 317, 325 (1986) (explaining that a movant without the burden of proof at trial can prevail by simply “pointing out to the district court … that there is an absence of evidence to support the nonmoving party’s case”). Here, Dunlap has failed to raise a genuine dispute as to any material fact relevant to whether the prison or its officials were “deliberate[ly] indifferen[t]” to his “serious medical needs,” Estelle v. Gamble, 429 U.S. 97, 104 (1976)—and he has failed to present material evidence showing that the prison or its officials knew of and disregarded “an excessive risk” to his “health and safety,” Colwell v. Bannister, 763 F.3d 1060, 1066 (9th Cir. 2014) (cleaned up), or that the prison and 2 its officials denied any treatment necessary for adequate care of his mental health condition, see Toguchi v. Chung, 391 F.3d 1051, 1060 (9th Cir. 2004) (clarifying the “high … standard” for such Eighth Amendment claims). And to the extent that Dunlap argues that the prison or its officials violated Idaho state law by declining to place him in the Acute Mental Health Unit, we reject that contention (to the extent it is adequately developed) as unmeritorious. Ultimately, Dunlap provides no material reason to conclude that the district court erred—and we affirm its grant of summary judgment. II Dunlap’s second line of attack also fails—the district court did not err in denying Dunlap’s motion for reconsideration. “Reconsideration is appropriate if the district court (1) is presented with newly discovered evidence, (2) committed clear error or the initial decision was manifestly unjust, or (3) if there is an intervening change in controlling law”—and “our review of a denial of a motion to reconsider is for abuse of discretion.” Sch. Dist. No. 1J, Multnomah Cnty., Or. v. ACandS, Inc., 5 F.3d 1255, 1262-63 (9th Cir. 1993); see Marlyn Nutraceuticals, Inc. v. Mucos Pharma GmbH & Co., 571 F.3d 873, 880 (9th Cir. 2009). Here, Dunlap has failed to establish that the district court abused its discretion in denying his motion for reconsideration. First, Dunlap has failed to identify any newly discovered evidence materially affecting the result—and he certainly never 3 presented such evidence to the district court. Second, Dunlap has failed to establish that the district court committed clear error or that its initial decision was manifestly unjust—indeed, he has not shown that the district court’s grant of summary judgment was even incorrect. And third, Dunlap has failed to identify any intervening change in the controlling law materially affecting the result. Ultimately, Dunlap provides no material reason to conclude that the district court erred—and we affirm its denial of Dunlap’s motion for reconsideration. AFFIRMED.1 1 Dunlap’s various motions—see Dkt. No. 7 (Motion for Injunctive Relief), Dkt. No. 13 (Motion to Certify Appeal), Dkt. No. 17 (Motion for Appointment of Counsel), Dkt. No. 24 (Motion to Take Judicial Notice), Dkt. No. 28 (Motion to Lift Briefing Stay and Issue Remand), Dkt. No. 31 (Motion for Issuance of Press Release), Dkt. No. 34 (Motion to Expand the Record), Dkt. No. 36 (Motion for Appointment of a Special Master), Dkt. No. 38 (Emergency Petition for a Writ of Mandamus), Dkt. No. 40 (Motion to Proffer, Seek Review, and Admission of Addendum), Dkt. No. 42 (Motion to Adopt Proposed Court Order), and Dkt. No. 44 (Motion to Proffer, Seek Review, and Commission of Supplemental Exhibits)—are DENIED. 4
Plain English Summary
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS JUL 31 2023 MOLLY C.
Key Points
Frequently Asked Questions
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS JUL 31 2023 MOLLY C.
FlawCheck shows no negative treatment for Timothy Dunlap v. Imsi in the current circuit citation data.
This case was decided on July 31, 2023.
Use the citation No. 9417045 and verify it against the official reporter before filing.
Why Attorneys Choose FlawFinder

Why Attorneys Choose FlawFinder

Side-by-side with Westlaw and LexisNexis

Feature FlawFinder Westlaw LexisNexis
Monthly price$19 – $99$133 – $646$153 – $399
ContractNone1–3 year min1–6 year min
Hidden fees$0, alwaysUp to $469/search$25/mo + per-doc
FlawCheck citatorIncludedKeyCite ($$$)Shepard's ($$$)
Plain-English summaryIncludedNoNo
CancelOne clickTermination feesAccount friction
Related Cases

Full legal research for $19/month

All 50 states · Federal regulations · Case law · Police SOPs · AI analysis included · No contract

Continue Researching →